格隆汇8月18日丨港通医疗(301515.SZ)在互动平台表示，公司专注于为各类医疗机构提供医用气体装备 及系统、医用洁净装备及系统，致力于解决医用气体供应及医疗感染问题。公司产品主要应用于医院病 房、手术室、ICU、中心供应室、各类实验室、高原弥散供氧等场景，公司的医用洁净装备及系统技术 可以应用于数据中心、实验室等的洁净处理。目前，公司客户主要为医院及医疗机构，尚未与脑机装备 公司形成业务往来。公司将根据市场调研分析，积极研发满足市场需求和符合公司发展的新产品。 ...

Core Viewpoint - The company focuses on providing medical gas equipment and systems, as well as medical clean equipment and systems, aiming to address medical gas supply and infection issues in healthcare settings [1] Group 1: Company Overview - The company specializes in supplying medical gas equipment and systems to various medical institutions [1] - Its products are primarily used in hospital wards, operating rooms, ICUs, central supply rooms, various laboratories, and high-altitude oxygen supply scenarios [1] - The company does not currently engage in the medical robotics business, such as fertility robots [1] Group 2: Future Outlook - The company will continue to monitor advancements in cutting-edge technologies [1] - It aims to enhance the intelligence level of its products to meet the modernization needs of hospitals [1]

人民财讯8月18日电，港通医疗（301515）今日在互动平台表示，目前，公司客户主要为医院及医疗机 构，尚未与脑机装备公司形成业务往来。 ...

Group 1 - The stock price of Kangtong Medical closed at 23.52 yuan on August 15, down 0.06 yuan, a decrease of 0.25% from the previous trading day [1] - The opening price was 23.56 yuan, with a daily high of 24.40 yuan and a low of 23.30 yuan, resulting in an intraday volatility of 4.66% [1] - There was a rapid rebound in the stock price, reaching 24.07 yuan at 9:35 AM, with a gain of over 2% within five minutes and a transaction amount of 11.3977 million yuan [1] Group 2 - Kangtong Medical operates in the medical device industry, focusing on medical engineering design and construction, as well as the research and manufacturing of medical equipment [1] - The company is based in Sichuan and holds the qualification of a specialized and innovative enterprise, also engaging in medical waste treatment [1] Group 3 - On August 15, the net inflow of main funds into Kangtong Medical was 3.7663 million yuan, with a cumulative net inflow of 4.7962 million yuan over the past five trading days [1] - The current circulating market value is 1.498 billion yuan, while the total market value stands at 2.352 billion yuan [1]

Core Viewpoint - As of August 14, 2025, the stock of Kangtong Medical (301515) closed at 23.58 yuan, down 1.34%, with a trading volume of 50,500 lots and a transaction amount of 119 million yuan [1] Group 1: Stock Performance and Fund Flow - On August 14, 2025, the net inflow of main funds was 2.24% of the total transaction amount, while retail investors experienced a net outflow of 10.82% [1] - Over the past five days, the stock has shown fluctuations, with a notable drop on August 14, where the main funds saw a net inflow of 267.46 million yuan [2] - The stock's performance over the last five days indicates a mixed trend, with varying net inflows and outflows from different investor categories [2] Group 2: Company Financials and Industry Comparison - Kangtong Medical's total market value is 2.358 billion yuan, significantly lower than the industry average of 11.792 billion yuan, ranking 123rd in the industry [3] - The company's net profit for the first quarter of 2025 was 1.579 million yuan, a decline of 85.25% year-on-year, indicating financial challenges [3] - The company's gross profit margin stands at 36.15%, which is below the industry average of 51.36%, ranking 93rd in the industry [3]

Core Viewpoint - On August 14, the stock price of Kangtong Medical exhibited volatility, with rapid fluctuations between declines and rebounds, closing at 23.58 yuan, down 1.34% from the previous trading day [1] Group 1: Stock Performance - The stock reached a high of 24.50 yuan and a low of 23.23 yuan, resulting in a price fluctuation of 5.31% [1] - The trading volume was 50,451 hands, with a total transaction amount of 119 million yuan [1] Group 2: Company Overview - Kangtong Medical specializes in the medical device sector, including medical waste treatment and other niche areas [1] - The company is part of the Sichuan sector and holds the qualification of a specialized and innovative enterprise [1] Group 3: Capital Flow - On August 14, the net inflow of main funds into Kangtong Medical was 2.6746 million yuan, with a cumulative net inflow of 5.3242 million yuan over the past five days [1] - During the trading session, a rapid rebound was observed at 10:34 AM, with a rise of over 2% within five minutes, followed by a quick pullback at 10:39 AM, with a drop of over 2% in the same timeframe, indicating active market trading [1]

8月14日，港通医疗今日收盘23.58元，下跌1.34%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到445.46倍，总市值23.58亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均55.76倍，行业中值39.14倍，港通医疗排 名第121位。 截至2025年一季报，共有1家机构持仓港通医疗，其中基金1家，合计持股数0.21万股，持股市值0.00亿 元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13港通医疗445.46163.501.8923.58亿行业平均 55.7651.784.91117.92亿行业中值39.1439.592.8556.79亿1九安医疗11.1811.310.88188.72亿2英科医疗 14.7815.931.32233.49亿3山东药玻16.1716.211.86152.90亿4新华医疗16.3115.111.33104.53亿5振德医疗 17.0416.061.0861.87亿6奥美医疗17.0716.731.7561.68亿7九强生物17.6516.412.1687.42亿8康德莱 18.2218.241.5139.27亿9奥泰生物18 ...

证券之星消息，港通医疗(301515)08月12日在投资者关系平台上答复投资者关心的问题。 投资者提问：请问到8.10股东人数是多少？ 港通医疗回复：尊敬的投资者，您好！公司截至2025年8月8日股东总户数为9469户，感谢您的关注。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - The core point of the article highlights the financing activities of Kangtong Medical, which had a financing buy-in amount of 0.15 billion yuan on August 11, ranking 2087 in the market [1] - Over the last three trading days from August 7 to August 11, Kangtong Medical received financing buy-ins of 0.08 billion yuan, 0.17 billion yuan, and 0.15 billion yuan respectively [1] - On the same day, the company had a financing repayment amount of 0.11 billion yuan, resulting in a net buy of 4.1457 million yuan [1] Group 2 - In terms of securities lending, there were no shares sold or net sold on that day, indicating no activity in this area for Kangtong Medical [2]

Group 1 - The core point of the article highlights that Kangtong Medical (301515) has recently registered a new software copyright for the "Medical Gas Alarm System Software V1.0" project, marking a total of 11 new software copyrights registered this year, which is a 57.14% increase compared to the same period last year [1] - In 2024, the company invested 24.2452 million yuan in research and development, which represents a year-on-year decrease of 18.83% [1] - Kangtong Medical has made investments in 12 enterprises and participated in 2,973 bidding projects, indicating active engagement in the market [1] Group 2 - The company holds 31 trademark registrations, 310 patents, and 35 copyright registrations, showcasing a robust intellectual property portfolio [1] - Additionally, Kangtong Medical possesses 106 administrative licenses, further indicating its compliance and operational capabilities within the industry [1]